Healthcare Roundup—Amazon, Berkshire Hathaway, JPMorgan name COO for health venture

Amazon trailer
Amazon, Berkshire Hathaway and JPMorgan Chase's joint healthcare venture now has a chief operating officer. (Amazon)

Amazon, Berkshire Hathaway, JPMorgan healthcare venture gets COO 

Jack Stoddard, who most recently served as at Comcast, has been selected to serve as the chief operating officer for Amazon, Berkshire Hathaway and JPMorgan Chase’s joint healthcare venture. 

Stoddard’s first day on the job was Tuesday after he left a position as digital health manager at Comcast to join the company. He’ll work alongside famed researcher and surgeon Atul Gawande, who was named CEO of the venture in June

Warren Buffett, CEO of Berkshire Hathaway, told Bloomberg that there is no “hurry” to fill leadership roles at the venture. 


13th Partnering with ACOS & IDNS Summit

This two-day summit taking place on June 10–11, 2019, offers a unique opportunity to have invaluable face-to-face time with key executives from various ACOs and IDNs from the entire nation – totaling over 3.5 million patients served in 2018. Exclusively at this summit, attendees are provided with inside information and data from case studies on how to structure an ACO/IDN pitch, allowing them to gain the tools to position their organization as a “strategic partner” to ACOs and IDNs, rather than a merely a “vendor.”

“We’d like to be in a hurry, but we’re not going to try and do something faster than it can be done,” Buffett said. (Bloomberg

FDA posts its policies for inspecting drug manufacturing facilities 

The Food and Drug Administration publicly posted its policies around inspections of drug manufacturing facilities, a move Commissioner Scott Gottlieb said is crucial as more manufacturing moves overseas. 

The policy explains how the FDA sets priorities and schedules for inspections. The agency weighs a facility’s compliance history, the length of time since it was last inspected and the risks associated with drugs under production when setting these priorities, Gottlieb said.

“We need to make sure our inspections are prioritized based on potential risks to patients, and that we’re using our resources efficiently,” Gottlieb said. 

The FDA also took multiple steps to ease the device approval process on Wednesday. (Statement

Healthcare costs remain a crucial concern for voters, Kaiser Family Foundation poll finds 

Healthcare is a key issue—particularly for Democrats—ahead of the midterm elections, with costs of particular concern. 

The Kaiser Family Foundation released the results of its latest Tracking Poll—in which more than 1,200 voters were polled in late August—and found that 32% of Democrats consider healthcare issues a top priority going into the midterms. In addition, 26% of independents and 20% of Republicans said the same. 

Among the respondents who said healthcare was an issue they wanted candidates to focus on, 29% of Democrats, 29% of independents and 25% of Republicans said costs were the main concern. The next-highest issue—increasing access—was noted by 13% of Democrats, 9% of independents and 4% of Republicans. (Poll

Suggested Articles

The FTC is suing Surescripts, accusing the health IT company of employing illegal restraints to maintain its monopolies over the e-prescribing market.

In the event of another economic downturn, health insurers would be more resilient today than they were in 2008, according to a new report.

Amid last week’s opioid prescriber crackdown, the Justice Department coordinated with local agencies to deploy health workers to help pain patients.